More tools:Markets·Screener·Research·Chat

TELA Bio, Inc. Common Stock (TELA) Financial Statements

TELA Bio, Inc. Common Stock
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG004CH7Z69
XNAS · usd
0.83▲ 0.01 (1.05%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close0.82
Day's Range0.81 – 0.87
52-Week Range0.50 – 1.73
Volume121.4K
Avg Volume255.1K
Share Statistics
Shares Outstanding
Employees218
ExchangeXNAS
Listed2019-11-08
Share count as of August 5, 2026
Loading Income Statement…
Key questions about TELA Bio, Inc. Common Stock (TELA)
What is TELA Bio, Inc. Common Stock's Market Cap?
TELA Bio, Inc. Common Stock's Market Cap is $37.3M, based on as-reported figures from SEC (XBRL) filings.
What is TELA Bio, Inc. Common Stock's Enterprise Value?
TELA Bio, Inc. Common Stock's Enterprise Value is $62.9M, based on as-reported figures from SEC (XBRL) filings.
What is TELA Bio, Inc. Common Stock's Price / Sales?
TELA Bio, Inc. Common Stock's Price / Sales is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is TELA Bio, Inc. Common Stock's EV / Revenue?
TELA Bio, Inc. Common Stock's EV / Revenue is 0.8×, based on as-reported figures from SEC (XBRL) filings.
What is TELA Bio, Inc. Common Stock's EV / EBITDA?
TELA Bio, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is TELA Bio, Inc. Common Stock's Revenue (TTM)?
TELA Bio, Inc. Common Stock's Revenue (TTM) is $79.9M, based on as-reported figures from SEC (XBRL) filings.
What is TELA Bio, Inc. Common Stock's Net Income (TTM)?
TELA Bio, Inc. Common Stock's Net Income (TTM) is -$41.2M, based on as-reported figures from SEC (XBRL) filings.
What is TELA Bio, Inc. Common Stock's EBITDA?
TELA Bio, Inc. Common Stock's EBITDA is -$33.4M, based on as-reported figures from SEC (XBRL) filings.
What is TELA Bio, Inc. Common Stock's Diluted EPS (TTM)?
TELA Bio, Inc. Common Stock's Diluted EPS (TTM) is -0.92, based on as-reported figures from SEC (XBRL) filings.
What is TELA Bio, Inc. Common Stock's EBITDA Margin?
TELA Bio, Inc. Common Stock's EBITDA Margin is -41.8%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Consolidated Statements of Operations and Comprehensive Loss
Revenue
YoY growth-4.5%+2.9%+18.2%+9.1%
Cost of revenue (excluding amortization of intangible assets)
Amortization of intangible assets
Gross profit
% of revenue72.3%65.7%65.9%67.5%
Operating expenses:
Sales and marketing
General and administrative
Research and development
Total operating expenses
% of revenue120.4%120.9%97.8%104.0%
Loss from operations
% of revenue48.1%55.2%-31.9%-36.5%
Other (expense) income:
Interest expense
Other income
Total other expense, net
Loss before income tax expense
Income tax expense
Net loss
% of revenue-58.4%-64.4%-43.3%-41.6%
Net loss per common share, basic (in dollars per share)
Net loss per common share, diluted (in dollars per share)